International Workshop on Oncology (IWO 2015)

Key Topics

• Cervical Cancer
• Breast Cancer
• Endometrial Cancer
• Diagnostics
• Adjuvant Therapy
• Organisation Of Gynaecologic Cancer Care
• Anal Cancer
• Allogeneic Bone Marrow
• Autologous Bone Marrow
• Angiogenesis
• Bladder Cancer
• Biomarkers And Correlative Studies From Immunotherapy Trials
• Cancer Angiogenesis And Metastases
• Bone Tumors
• Cancer Prevention
• Cancer Genetics
• Cancer Stem Cell Pathway
• Cancer Prevention/Epidemiology
• Central Nervous System Tumors
• Cell Cycle And Checkpoints
• Colorectal Cancer
• Circulating Tumor Cells
• Cytotoxic Chemotherapy
• Cytotoxic And Other Novel Agents
• Developmental Therapeutics-Immunotherapy
• Developmental Therapeutics-Clinical Pharmacology And Experimental Therapeutics
• End-Of-Life Care
• DNA Repair And Apoptosis
• Epigenetics
• Epidemiology
• Fertility / Pregnancy
• Esophageal Or Gastric Cancer
• Gastrointestinal (Noncolorectal) Cancer
• Gastrointestinal (Colorectal) Cancer
• Genitourinary (Nonprostate) Cancer
• Gastrointestinal Stromal Tumors (GIST)
• Geriatric Oncology
• Genomic And Epigenomic Biomarkers
• Gynecologic Cancer
• Germ Cell/Testicular
• Hepatobiliary Cancer
• Head And Neck Cancer
• Immunotherapy And Biologic Therapy
• Immunobiology
• Leukemia
• Kidney Cancer
• Leukemia, Myelodysplasia, And Transplantation
• Leukemia Or Lymphoma
• Local-Regional Non-Small Cell Lung Cancer
• Local Therapy
• Lymphoma
• Lung Cancer-Non-Small Cell Metastatic
• Melanoma/Skin Cancers
• Lymphoma And Plasma Cell Disorders
• Metastatic Non-Small Cell Lung Cancer
• Mesothelioma
• Multiple Myeloma
• Molecular Diagnostics And Imaging
• Nanotechnology
• Myeloproliferative Syndromes
• New Targets And New Technologies
• Neuroendocrine/Carcinoid
• Palliative Care
• Ovarian Cancer
• Patient And Survivor Care
• Pancreatic Cancer
• Pediatric Solid Tumors
• Pediatric Oncology
• PI3-Akt-MTOR Pathway
• Pharmacology
• Prevention Of Gynaecologic Cancer
• Plasma Cell Disorders
• Proteomic And Metabolomic Biomarkers
• Prostate Cancer
• Quality Of Life After Treatment Of Gynaecologic Cancer
• Psychosocial Research
• Signal Transduction
• Radiation Biology
• Small Cell Lung Cancer
• Small Bowel Cancer
• Stem Cell Support
• Soft Tissue
• Symptom Managements/Supportive Care/Palliative Care
• Symptom Management/Supportive Care
• Translational Research
• Thymic Malignancies
• Trophoblastic Diseases
• Triple-Negative Breast Cancer
• Vaccines
• Uterine Cancer
• Viral Therapy
• Vaginal And Vulvar Cancer

Who should Attend

Researchers and practitioners with an interest in Oncology.